Coronavirus vaccine administered through the intramuscular injection route protects the lower lungs but not the upper lung. Nasal vaccines can protect the lungs completely and stop transmission and also infection

Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is expected to be at least 60 per cent effective

Modi insisted on continued social distancing and COVID-appropriate behaviour such as wearing masks, regularly washing hands and sanitation, especially during upcoming festival season

China has said that while reasonable profits for companies are permitted, COVID-19 vaccines should be priced close to cost

A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years

Civil society groups say there is an inequality of access to critical technologies that are needed to address the pandemic; they want WTO member countries to unequivocally support the adoption of the IP Waiver proposal

According to World Health Organisation's chief scientist, Dr Soumya Swaminathan said, health workers, elderly and frontline workers might get the COVID-19 vaccine first, though the prioritisation details are still being worked out by the WHO

Overseas, Asian equities were trading mixed tracking overnight fall in US markets as investors awaited Chinese President's speech. Investors sentiment was hit after select drug-makers faced setbacks in vaccine trials of COVID-19

India Stock Market Highlights Today: Tata Steel, Bharti Airtel, HCL Tech, Asian Paints and Bajaj Auto were among the top laggards today. On the other hand, ONGC, followed by NTPC, PowerGrid, UltraTech Cement, ITC, HDFC Bank, ICICI Bank and HDFC were among the top gainers.

The country's state medical research agency had given a go-ahead to the Phase III trial in July and government approval came a month later

China was the first to report the outbreak, identified the pathogen and shared the genome sequence with the world, said Chinese Foreign Ministry spokesperson

Initially, China did not agree to join the alliance, missing the global deadline to join in September

China has at least four experimental vaccines in the final stage of clinical trials

Hundreds of thousands of essential workers and other groups considered at high risk in China have been given locally-developed vaccines even as clinical trials had not been fully completed, raising safety concerns among experts

Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites

British Prime Minister Boris Johnson made a special reference to India's role in the manufacture and access to one of the most promising coronavirus vaccine candidates currently undergoing trials during his address to the United Nations (UN) General Assembly

The number of deaths about nine months since the novel coronavirus was discovered in China is nearing 10 lakh

COVID-19 vaccine: China claims WHO gave support, understanding for emergency use programmeThe World Health Organization gave China its support and understanding to start administering experimental coronavirus vaccines to people while clinical trials were still underway, a Chinese health official said on Friday. China launched its emergency programme in July, having communicated with the WHO in late June, according to  a National Health Commission official. Hundreds of thousands essentia...

China launched its emergency programme in July, having communicated with the WHO in late June, according to Zheng Zhongwei, a National Health Commission official

Stringent regulations in the U.S., European Union, Japan and Australia have historically blocked the sale of Chinese vaccines